BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet … – PR-inside.com (press release)

posted on Mar 01 by in the Uncategorized category

BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet ...
PR-inside.com (press release)
Notes to the Editor About pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized ...
BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet ...PipelineReview.com (press release)

all 33 news articles »

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes